For research/education only. Not medical advice, not FDA-evaluated. Buyers 18+ assume all responsibility.

Synergistic peptide blend for multi-pathway metabolic research.

Triple agonist (GIP/GLP-1/Glucagon) for next-generation metabolic studies.

Selective GLP-1 receptor agonist for glucose control and fat loss research.

Dual GLP-1 and GIP receptor agonist for advanced metabolic research.